Business Wire - Court Rules for Pfizer in Patent Infringement Case on Neurontin
Monday, December 1st, 2008 NEW YORK — Pfizer Inc said today that an appeals court has overturned a lower court ruling that several generic manufacturers did not infringe the company’s patent for stabilized formulations of gabapentin, the active ingredient in Neurontin.
The Court of Appeals for the Federal Circuit r…
